Cara Sommerlot, EDS | |
820 N Washington Ave, Madison, SD 57042-1735 | |
(605) 256-5555 | |
Not Available |
Full Name | Cara Sommerlot |
---|---|
Gender | Female |
Speciality | Psychologist - School |
Location | 820 N Washington Ave, Madison, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518415454 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TS0200X | Psychologist - School | 69234-1 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cara Sommerlot, EDS 820 N Washington Ave, Madison, SD 57042-1735 Ph: (605) 256-5555 | Cara Sommerlot, EDS 820 N Washington Ave, Madison, SD 57042-1735 Ph: (605) 256-5555 |
News Archive
In 2010, the European Council described sharps injuries as one of the most serious health and safety threats in European workplaces as an estimated one million injuries were occurring each year.
A study published online as an accepted paper in the Journal of Clinical Sleep Medicine found that increased physical activity is associated with a lower risk of obstructive sleep apnea, a common sleep-related breathing disorder.
The process of cell division is tightly regulated, as mistakes may lead to cancer. The so-called c-JUN protein has been fingered as causing tumours in both skin and liver. It has long been known to have a direct role in reducing the expression of a gene (p53) that leads to the death of abnormal cells and to activate transcription of a further gene (CyclinD1) that directly promotes cell division.
Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers from the Université de Montréal School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre in collaboration with researchers at Boston University School of Medicine.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced the initiation of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of Z944, a novel oral T-type calcium channel blocker with demonstrated preclinical potential for the treatment of acute and inflammatory pain.
› Verified 5 days ago
Penny Petrik, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 820 N Washington Ave, Heartland Building, Madison, SD 57042 Phone: 605-256-5555 | |
Lance Koenig, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 820 North Washington Ave, Plec Dakota State University, Madison, SD 57042 Phone: 605-256-5555 | |
Mrs. Renae Christensen, ED.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 820 N. Washington Ave., Madison, SD 57042 Phone: 605-256-5555 |